IL6 and Alzheimer disease: Specifically in Alzheimer’s disease, it has been shown that in addition to plaques and neurofibrillary tangles, chronic neuroinflammation is the third main pathological feature of Alzheimer’s disease, and is generated by the activation of microglia cells and the release of cytokines [87] such as TNF-α, a proinflammatory cytokine, which is elevated in patients with Alzheimer’s disease [88,89] as well as IL-6, IL-12, and IL-18, IFN-γ, chemokine (MCP-1), and other neurotoxic agents [90,91].